BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a national specialty pharmacy benefit manager (SPBMTM) serving commercial, Medicare and Medicaid segments, announces the launch of its national Infusion Management Program designed to help employers carve out specialty pharmacy, including high cost infusion therapies. This unique program for medical drug spend optimizes plan performance, generates savings and offers significant advantages, including improved patient safety and health outcomes, identification of appropriate sites of care, reduced waste and cost, negotiated dispensing rates and increased cost transparency.
“This program could not come at a more propitious time as specialty drugs now represent the fastest-growing area of spend for employers,” says Dea Belazi, president and CEO, noting the top 10 most expensive drugs in the United States range from over $633,000 to well over $2.1 million annually. “Because drugs typically fall under the medical benefit management, medical infusion costs are misaligned and have created unstructured pricing that leaves employers and other payers in the dark about the true cost of therapy. AscellaHealth’s Infusion Management Program achieves accountability and effectively manages the medical drug benefit for employers, delivering cost savings while maintaining optimal patient care.”
Using proprietary financial models combined with superior technology and analytics, AscellaHealth offers flexible, tailored drug management solutions driven by actual client needs. The program seamlessly integrates available specialty pharmacy networks, discount pricing, manufacturer rebates and copay assistance programs to lower the overall cost of providing needed medications. This approach offers transparency, waste/dose optimization, quality and value, actionable real-time data and integrated pharmacy support and collaboration.
AscellaHealth’s Site of Care and Specialty HUB Model allows the patient care team to work closely with patients and prescribers to determine the optimal treatment and enhance drug regimen optimization.
“AscellaHealth determines the right treatment by leveraging readily available economical and clinical cost outcomes that drive the best viable outcome for the member,” continues Belazi. “With infusion therapies, this involves investigating the best route of infusion—and the best site of care. The patient care team works closely with patients and prescribers to determine the optimal location from a pricing perspective while maintaining medication delivery and administration standards.”
Clients in the AscellaHealth Infusion Management Program gain a flexible structure that goes after the best results for their group. The AscellaHealth team determines whether shifting J Code drugs to the pharmacy benefit is the best option for that client based on savings and quality of care outcomes. Program leaders ensure that the lines of communication stay open between physician, pharmacy and patient, and prioritize patient safety and access to proper treatment for all cases.
AscellaHealth, a national specialty pharmacy benefit manager (SPBMTM), serving commercial, Medicare and Medicaid segments, offers high quality prescription drug benefit management services. Complemented by other customizable services, such as carved-out specialty pharmacy services and cost-savings programs, AscellaHealth provides a unique, proprietary service portfolio. Visit www.ascellahealth.com.